Company PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 21/03/2025			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

Business description: PCL, Inc.

PCL Inc is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Companyâ€™s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Number of employees: 31

Sales by Activity: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Vitro Diagnostics-Related Business	53.68B	46.15B	37.22B	8.43B	1.25B

See all business segments

Geographical breakdown of sales: PCL, Inc.

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
South Korea	3.91B	599M	28.13B	2.92B	1.17B
Other	-	-	-	138M	34.09M
Asia	-	-	-	3.87B	19.75M
Europe	-	-	-	1.48B	-
Overseas	49.77B	45.55B	9.08B	-	-

See all geographic segments

Executive Committee: PCL, Inc.

Manager	Title	Age	Since
So-Yeon Kim CEO	Chief Executive Officer	55	-
Seong-Woo Lee SAM	Sales & Marketing	42	28/03/2024
Mu-Yong So AUD	Comptroller/Controller/Auditor	53	28/03/2024
Won-Hee Jang AUD	Comptroller/Controller/Auditor	53	31/03/2025
Seung-Ki Hong AUD	Comptroller/Controller/Auditor	72	-

See PCL, INC. governance

Composition of the Board of Directors: PCL, Inc.

Director	Title	Age	Since
Chul-Joon Kim BRD	Director/Board Member	73	-
So-Yeon Kim BRD	Director/Board Member	55	-
Mu-Yong So BRD	Director/Board Member	53	28/03/2024
Seong-Woo Lee BRD	Director/Board Member	42	28/03/2024
Dae-Yeol Kim BRD	Director/Board Member	49	31/03/2023

Composition of the Board of Directors

Shareholders: PCL, Inc.

Name	Stocks	%	Valuation
So-Yeon Kim 0.8415 %	497,910	0.8415 %	105 193 ₩
In-gyu Kim 0.0191 %	11,284	0.0191 %	2 384 ₩
Ji-won Lee 0.004958 %	2,934	0.004958 %	620 ₩
Seung-hyun Lee 0.004958 %	2,934	0.004958 %	620 ₩
Ji-woon Jang 0.000786 %	465	0.000786 %	98 ₩

List of PCL, INC. shareholders

Company details: PCL, Inc.

PCL, Inc.

99 Digital-ro 9-gil

08510, Seoul

http://www.pclchip.com

Bio Diagnostics & Testing

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PCL, INC.	-1.63%	-.--%	-.--%	-87.97%	11.9M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-0.55%	+2.64%	+99.45%	+303.35%	4.05B
VERACYTE, INC.	-3.73%	-3.19%	+55.30%	+76.18%	3.73B
IOVANCE BIOTHERAPEUTICS, INC.	+3.85%	+55.30%	+202.24%	-5.34%	2.94B
CAREDX, INC.	+0.17%	+3.98%	+279.70%	+406.26%	2.44B
BGI GENOMICS CO., LTD.	-2.25%	+3.46%	-23.79%	-31.51%	2.35B
FREENOME, INC.	-0.60%	+6.51%	+9.93%	-	1.35B
SEEGENE, INC.	-1.84%	+14.31%	+15.55%	+44.24%	1.05B
MARAVAI LIFESCIENCES HOLDINGS, INC.	-0.52%	-9.83%	+114.87%	-42.49%	866M
HANGZHOU ALLTEST BIOTECH CO., LTD.	-1.62%	+8.87%	-34.79%	-0.85%	572M
Average	-0.39%	+7.23%	+71.85%	+73.54%	1.94B
Weighted average by Cap.	-0.38%	+9.80%	+100.20%	+134.60%